Germline pathogenic PTEN variant in a patient with a Kaposiform haemangioendothelioma.

Cancer GenetJul 1, 2026 (epub)

Hannah Massey, Karim El Shakankery, Stefan N Symeonides et al.

✦ AI-curated · Sources linked

Case in brief

A 28-year-old female presented with Kaposiform haemangioendothelioma (KHE) and was found to have a germline pathogenic PTEN variant. Initial detection in tumor tissue was confirmed in saliva. Reverse phenotyping revealed features consistent with PTEN Harmatoma Tumour Syndrome, including large head circumference and skin lesions. The case highlights the importance of genomic profiling in diagnosing inherited cancer susceptibility disorders.

What made this case unusual

This case is notable for the association of a malignant vascular neoplasm, KHE, with PTEN Harmatoma Tumour Syndrome, which has not been well documented previously.

Diagnostic / clinical pearl

Clinicians should consider genetic testing for PTEN variants in young patients with KHE, especially when accompanied by subtle features of PTEN Harmatoma Tumour Syndrome.

Why it matters

This case underscores the potential for malignant vascular tumors to be associated with inherited cancer susceptibility syndromes, expanding the understanding of PTEN's role in tumorigenesis.

Source

Published in Cancer Genet. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Medical Genetics

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.